(S)-(+) -3-Hydroxytetrahydrofuran CAS 86087-23-2 Ịdị Ọcha> 99.0%(GC) Afatinib Amprenavir Fosamprenavir Intermediate egosipụtara

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Dị Ọcha> 99.0%(GC) Afatinib Amprenavir Fosamprenavir Intermediate

Nkọwa dị mkpirikpi:

Aha kemịkal: (S)-3-Hydroxytetrahydrofuran

Nọmba: 86087-23-2

Mmiri mmiri na-acha odo odo na-enweghị ntụpọ

Ịdị Ọcha:>99.0%(GC) Ọcha anya:>99.0% (GC)

Ndị nọ n'etiti Afatinib, Amprenavir, Fosamprenavir

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye nrụpụta;Ngwaahịa na-ekpo ọkụ;Ịdị ọcha dị elu na ọnụ ahịa asọmpi
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
Afatirib CAS 439081-18-2,Afatinib Dimaleate CAS 850140-73-7Isi etiti
Amprenavir (CAS 161814-49-9) na Fosamprenavir (CAS 226700-79-4) Intermediate

Njirimara kemịkalụ:

Aha Chemical	(S) -3-Hydroxytetrahydrofuran
Ụdị okwu	(S)-(+) -3-Hydroxytetrahydrofuran;(S) -Tetrahydrofuran-3-ol;(S)-(+) -Tetrahydro-3-Furanol
Nọmba CAS	86087-23-2
Nọmba CAT	RF-CC101
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C₄H₈O₂
Ibu molekụla	88.11
Ebe esi nri	80 ℃ / 15 mmHg (ọkụ)
Njupụta	1.103 g/mL na 25 ℃ (ọkụ)
Ntụgharị uche	n20/D 1.45 (ọkụ)
Mmiri Solubility	Soluble
Ọnọdụ mbupu	Ebugara n'okpuru okpomọkụ gburugburu
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Mmiri mmiri na-acha odo odo na-enweghị ntụpọ
Ụzọ ịdị ọcha / nyocha	> 99.0% (GC)
njirimara	Oge njide nke sample kwesịrị dakọtara na oge njide nke ọkọlọtọ
Ntụgharị akọwapụtara[a]_D²⁰	+17.5° ± 2.5° (C=2 na MeOH)
Ịdị ọcha anya	ee> 99.0% (GC)
Mmiri (KF)	<0.50%
(R)-(-)-3-Hydroxytetrahydrofuran	<0.15%
Ọdịghị ọcha ọ bụla ọzọ	<0.40%
Mgbakọta adịghị ọcha	<1.00%
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Nke abụọ nke Afatinib, Afatinib Dimaleate, Amprenavir na Amprenavir Phosphate.

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 ROS

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Fluoride Barrels, 25kg/Barrel, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

Ike zuru oke: akụrụngwa na ndị ọrụ nka zuru oke

Ọrụ Ọkachamara: Otu nkwụsị ịzụrụ ọrụ

Ihe ngwugwu OEM: ngwugwu omenala na akara dị

Nnyefe ngwa ngwa: Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ

Nkwanye kwụsiri ike: Jikwaa ngwaahịa ezi uche dị na ya

Nkwado nka na ụzụ: Ngwọta teknụzụ dị

Ọrụ Synthesis Custom: sitere na gram ruo kilos

Ogo dị elu: guzobe usoro mmesi obi ike zuru oke

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ ndị na-eduga emeputa na soplaya nke (S)-(+) -3-Hydroxytetrahydrofuran (CAS: 86087-23-2) na elu àgwà, ọtụtụ ebe na-eji na njikọ nke ọgwụ intermediates na Active Pharmaceutical. Ngwa (API).(S)-(+) -3-Hydroxytetrahydrofuran bụ isi etiti nke Afatinib (CAS 439081-18-2), Afatinib Dimaleate (CAS: 850140-73-7), Amprenavir (CAS 161814-49-9) na Fosamprenavir CAS 226700-79-4).Afatinib (CAS 439081-18-2) bụ onye nwere ike, covalent/apụghị ịgbagha agbagha, yana ọnụ bioavailable dual (EGFR/ErbB) tyrosine kinase (RTK) inhibitor nwere ọrụ anticancer.Afatinib (CAS 439081-18-2) bụ ọgwụ ndenye ọgwụ nwere ike ị were ọnụ maka ọgwụgwọ ọrịa cancer akpa ume na-abụghị obere cell (NSCLC) yana ndị nnọchi anya Epidermal Growth Factor Receptor (EFGR).Amprenavir (CAS 161814-49-9) bụ ihe mgbochi nje nje HIV eji agwọ nje HIV.Amprenavir bụkwa ihe mgbochi SARS-CoV 3CLpro nwere IC50 nke 1.09 μM.Fosamprenavir (Amprenavir phosphate; GW 433908) bụ phosphate ester prodrug nke antiretroviral protease inhibitor Amprenavi.